Post-infection immunodeficiency virus control by neutralizing antibodies
about
Sang Froid in a time of trouble: is a vaccine against HIV possible?Patterns of HIV/SIV Prevention and Control by Passive Antibody ImmunizationAnimal models for HIV/AIDS researchLimited impact of passive non-neutralizing antibody immunization in acute SIV infection on viremia control in rhesus macaques.Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques.A novel protective MHC-I haplotype not associated with dominant Gag-specific CD8+ T-cell responses in SIVmac239 infection of Burmese rhesus macaques.Association of major histocompatibility complex class I haplotypes with disease progression after simian immunodeficiency virus challenge in burmese rhesus macaques.Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.Improved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4+ T-cell loss and higher titers of neutralizing antibodyPolyfunctional CD4+ T-cell induction in neutralizing antibody-triggered control of simian immunodeficiency virus infection.Control of simian immunodeficiency virus replication by vaccine-induced Gag- and Vif-specific CD8+ T cells.Engineering broadly neutralizing antibodies for HIV prevention and therapy.Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development.Elite control of HIV infection: implications for vaccine design
P2860
Q27487961-E745772E-5D55-4594-899D-C49F82F77891Q28068018-BA8FE283-1E66-456B-8B7A-4EA71C76783DQ30423656-F5A0E000-B2E8-4F75-9C03-2C8D405FF1CAQ31138949-A9FD5AB6-7331-4B9B-9D2E-39133105E06BQ33558279-8736717B-7BDD-403D-A6F7-4A9D5683ADDDQ34185625-2F45C501-C229-4123-9BB3-4F9BD370E675Q34559322-99997894-B090-482A-92DE-602754CE7A1FQ36086627-E8CA3F7C-DED2-4043-8E02-F37656FD563BQ37073319-2E76BD80-FE11-4920-BB88-DD9CD9363F98Q37191899-3BA6A3A0-7E7C-4F53-B1EC-2FA41FD22B48Q37191948-566A95A4-9E82-4B61-ACDD-F057E5C62069Q37547813-73D4BFE1-F4B3-453B-917F-24A816C0B052Q38717198-64CEEC1D-52C7-4189-8598-F0B8C8E27552Q42159772-5301387D-48F3-47A7-9DA2-D4D4E4BDF600Q56994404-E7F22F12-70B4-4A54-A2FE-51E6440597BE
P2860
Post-infection immunodeficiency virus control by neutralizing antibodies
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Post-infection immunodeficiency virus control by neutralizing antibodies
@ast
Post-infection immunodeficiency virus control by neutralizing antibodies
@en
type
label
Post-infection immunodeficiency virus control by neutralizing antibodies
@ast
Post-infection immunodeficiency virus control by neutralizing antibodies
@en
prefLabel
Post-infection immunodeficiency virus control by neutralizing antibodies
@ast
Post-infection immunodeficiency virus control by neutralizing antibodies
@en
P2093
P2860
P1433
P1476
Post-infection immunodeficiency virus control by neutralizing antibodies
@en
P2093
Akiko Takeda
Hiroko Igarashi
Hiroyuki Yamamoto
Miki Kawada
Tetsuro Matano
P2860
P356
10.1371/JOURNAL.PONE.0000540
P407
P577
2007-06-20T00:00:00Z